RESP-1000 series (Respiratorius)

N/A

Report date: 2025/01/26 16:57:54
NME

Base Information

Drug NameRESP-1000 series (Respiratorius)
Drug Alias Nameanti-inflammatory bronchodilators (Respiratorius)RESP-1125
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonistsC-C motif chemokine 2 inhibitors
TargetsLeukotriene B4 receptorC-C motif chemokine 2
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRespiratorius
China Registration ClassN/A

Develop Information

Active CompaniesRespiratorius
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A